Skip to main content
RLMD logo

RLMD · Relmada Therapeutics, Inc. · Documents

Track RLMD — free
$3.39 +0.23 (+7.28%)
Market Cap
$337.08M
Shares
106.67M
Volume · Oct 20 739.39K Avg daily vol (3M) 1.26M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type AI summary Filing Date Period Open
Showing 1–50 of 120 filings
Key facts CIK 1553643 CUSIP 75955J402 13F (30d) 5 filings 5 filers Visit website Investor relations